Phase 3 study for Metastatic Pancreatic Cancer

To compare the efficacy of AM0010 in combination with FOLFOX versus FOLFOX alone in patients with metastatic pancreatic cancer as measured by OS. • To compare the efficacy of AM0010 in combination with FOLFOX versus FOLFOX alone in patients with metastatic pancreatic cancer as measured by: o PFS o ORR by RECIST v.1.1 • To compare the safety and tolerability of AM0010 in combination with FOLFOX versus FOLFOX alone

August 09, 2017